Study Summary
This trial is testing a new treatment for keratoconus, a disease that causes the cornea to become thin and misshapen. The new treatment, called corneal cross-linking, involves using a special solution and light to strengthen the cornea.
- Progressive Keratoconus
Treatment Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 6 Months
Trial Safety
Trial Design
5 Treatment Groups
Group 3 / Cohort 2
1 of 5
Group 4 / Cohort 2
1 of 5
Group 5 / Cohort 2
1 of 5
Group 1 / Cohort 1
1 of 5
Group 2 / Cohort 2
1 of 5
Active Control
Experimental Treatment
Non-Treatment Group
150 Total Participants · 5 Treatment Groups
Primary Treatment: NXL Energy 3 · Has Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 55 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Missouri | 100.0% |
What site did they apply to?
| Glaukos Investigative Site | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Why did patients apply to this trial?
- "I have progressive KC in both eyes treated left in 2018 and needing treatment in right after condition worsening. Ideally help can keep me from further issues and help others dealing with my illness."
How many prior treatments have patients received?
| 1 | 100.0% |
Frequently Asked Questions
How many participants have been accepted into this clinical experiment?
"Affirmative. According to clinicaltrials.gov, the recruitment process for this trial commenced on March 8th 2022 and was recently updated on March 29th 2022. Currently, 150 volunteers are needed at 4 distinct sites." - Anonymous Online Contributor
Is the enrollment of individuals aged 35+ being considered for this clinical trial?
"The eligibility conditions for this trial state that individuals aged between 18 and 55 are able to participate. For those under the age of 18, there are a total of 18 studies available while 35 trials exist for seniors over 65 years old." - Anonymous Online Contributor
Could I be qualified to participate in this medical trial?
"Aspiring enrollees need to meet two criteria: they must have progressive keratoconus and be aged between 18-55. This clinical trial is aiming to include a total of 150 participants." - Anonymous Online Contributor
Is this research endeavor recruiting participants at the present time?
"Clinicaltrials.gov reveals that this research project, which was first published on March 8th 2022, is actively recruiting new participants. The post has been updated as recently as March 29th of the same year." - Anonymous Online Contributor
How many distinct sites are currently hosting this investigation?
"Currently, 4 sites are running the trial. These include Boston, Dothan and Westerville as well as four other locales. To minimize traveling costs for participants, it is recommended to select the closest available medical centre." - Anonymous Online Contributor